Infectious diseases in solid organ transplant recipients: Analysis of autopsied cases in Japan

Yuhko Suzuki1, Akira Kenjo2, Tomiteru Togano3

  • 1Department of Blood Transfusion and Transplantation Immunology, Fukushima Medical University, Fukushima, Fukushima, Japan.

Abstract

Insights

Visceral mycoses (VM) are common after solid organ transplantation (SOT). Fulminant hepatitis increases the risk of VM in liver transplant recipients, highlighting the need for better diagnosis and treatment.

Area of Science:

  • Medical Mycology
  • Transplant Infectious Diseases
  • Epidemiology

Background:

  • Infections, particularly mycoses, are significant complications following solid organ transplantation (SOT) due to advancements in immunosuppression and graft survival.
  • Visceral mycoses (VM) represent a major concern in the post-transplant period.

Purpose of the Study:

  • To analyze the epidemiology of VM in autopsy cases in Japan, focusing on SOT recipients.
  • To identify risk factors for VM in SOT recipients, particularly liver transplant recipients.

Main Methods:

  • Continuous updating of an epidemiological database of VM in Japanese autopsy cases since 1989.
  • Compilation of data on infectious agents and clinical information from autopsy cases, including SOT recipients.

Main Results:

  • VM occurred in 14.3% of SOT recipients, a significantly higher incidence than in non-transplanted cases.
  • Aspergillus spp. was the most common fungal agent, followed by Candida spp. Aspergillus was predominant in liver and lung transplant recipients.
  • Fulminant hepatitis (FH) was identified as an independent risk factor for VM in liver transplant recipients (OR 3.61, P=0.03).

Conclusions:

  • This epidemiological study underscores the high incidence of VM in SOT recipients.
  • Intensified diagnostic and therapeutic strategies for post-SOT infections are warranted based on these findings.

Related Concept Videos

Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...